AGP Picks
View all

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on July 16, 2026

DT Midstream to Announce Second Quarter 2026 Financial Results, Schedules Earnings Call
Azimut and KGHM Launch 2026 Campaign at Kukamas
Diagonal Therapeutics Announces First Patient Dosed in Phase 1/2 DIAMOND Clinical Trial of DIAG723 for Hereditary Hemorrhagic Telangiectasia (HHT)
First Atlantic Nickel & Cobalt Expands Alloy Max Zone 445 Meters South of the Discovery Hole: XL-26-16, the Deepest Hole to Date at Pipestone XL, Intersects Large-Grain Visible Awaruite (Ni-Fe-Co Alloy) Over Its Entire 525-Meter Length, Ending in Open…
Azimut et KGHM débutent la campagne 2026 sur Kukamas
Wabash Announces Pricing of Upsized Offering of $130 Million Convertible Senior Notes
OFinancial Strengthens Global Regulatory Presence with New Mauritius FSC Licence
BingX Accelerates Multi-Asset Expansion with Strong Q2 Growth
Bunker Hill Mining Strengthens Executive Team and Achieves Improved ESG Rating in Latest Digbee Assessment
Monumental Chinese Treasures Shine at Xiling Yinshe 2026 Spring Auction in Hangzhou
Blossom Gold Announces the Reopening of Portal #2 Underway at Rosebud
Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year
Ragnarok: The New World Officially Launched in Southeast Asia on July 16, 2026
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
O comércio eletrônico brasileiro entra em uma nova era do consumo interativo
Brazilian E-Commerce Enters a New Era of Interactive Consumption
Data Center Security Market to Reach US$65.26 Billion by 2034 as AI-Driven Cybersecurity and Zero-Trust Adoption Accelerate
FREELANDER Confirms September Abu Dhabi Brand Launch at Goodwood Festival of Speed, Marking the Next Step in Global Expansion
4TEEN4 Receives U.S. FDA Fast Track Designation for Invobenitug in Cardiogenic Shock
Arletta Pharma Solutions Receives FDA Response Supporting the Clinical Development Program of Lybrido™ for Female Sexual Interest/Arousal Disorder in the US

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Telecoms Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.